Yili Chuanning Biotechnology Co.,Ltd. (SHE:301301)
China · Delayed Price · Currency is CNY 9.83
-0.01 (-0.10%)
At close: Dec 12, 2025
SHE:301301 Market Cap
SHE:301301 has a market cap or net worth of 21.92 billion as of December 12, 2025. Its market cap has decreased by -25.77% in one year.
Market Cap
21.92B
Enterprise Value
22.43B
Revenue
4.74B
Ranking
n/a
PE Ratio
23.53
Stock Price
9.83
Market Cap Chart
Since December 27, 2022, SHE:301301's market cap has decreased from 22.34B to 21.92B, a decrease of -1.87%. That is a compound annual growth rate of -0.63%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Dec 12, 2025 | 21.92B | -17.01% |
| Dec 31, 2024 | 26.41B | 41.47% |
| Dec 29, 2023 | 18.67B | -6.15% |
| Dec 30, 2022 | 19.89B | -10.95% |
| Dec 27, 2022 | 22.34B | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Jiangsu Hengrui Pharmaceuticals Co.,Ltd | 419.80B |
| WuXi AppTec | 279.36B |
| Shenzhen Mindray Bio-Medical Electronics | 241.66B |
| Sichuan Biokin Pharmaceutical | 148.61B |
| Shanghai United Imaging Healthcare | 105.48B |
| Aier Eye Hospital Group | 103.27B |
| Zhangzhou Pientzehuang Pharmaceutical., | 103.09B |
| Yunnan Baiyao Group Co.,Ltd | 99.62B |